drugset
drugset / Trial / NCT02176668

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

NCT02176668 ↗

Phase 1 Completed 82 enrolled Yuhan Corporation
RandomizedParallel-groupOpen-labelOther

Summary

The objective of this clinical trial is to explore pharmacodynamics and pharmacokinetics of YH4808 New Formulation in healthy volunteers.

Timeline

Start
2014-06
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject YH4808 Other / unclassified 100 mg Oral
Subject YH4808 Other / unclassified 200 mg Oral
Subject YH4808 Other / unclassified 400 mg Oral

Indications

No indication recorded.